Podchaser Logo
Home
FDA Approval Insights: Ponatinib in Ph+ ALL

FDA Approval Insights: Ponatinib in Ph+ ALL

Released Monday, 8th April 2024
Good episode? Give it some love!
FDA Approval Insights: Ponatinib in Ph+ ALL

FDA Approval Insights: Ponatinib in Ph+ ALL

FDA Approval Insights: Ponatinib in Ph+ ALL

FDA Approval Insights: Ponatinib in Ph+ ALL

Monday, 8th April 2024
Good episode? Give it some love!
Rate Episode

Unlock Episode Insights with

Podchaser Logo PRO

Reach • Demographics • Contacts • More

Pro Features

Audience & Reach for FDA Approval Insights: Ponatinib in Ph+ ALL

See a breakdown of Audience & Reach for FDA Approval Insights: Ponatinib in Ph+ ALL

Unlock Episode Audience & Reach with Podchaser Pro

Brand Safety for FDA Approval Insights: Ponatinib in Ph+ ALL

See Brand Safety for FDA Approval Insights: Ponatinib in Ph+ ALL

Unlock Episode Brand Safety with Podchaser Pro

Ad Rate Card of OncLive® On Air

How much does it cost to advertise on OncLive® On Air?

PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.

Frequently Asked Questions about OncLive® On Air

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features